CFG
EBS icon

Citizens Financial Group’s Emergent Biosolutions EBS Stock Holding History

Citizens Financial Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-213
Closed -$17K – 433
2020
Q2 		$17K Hold
213
– – ﹤0.01% 653
2020
Q1 		$12K Hold
213
– – ﹤0.01% 703
2019
Q4 		$11K Hold
213
– – ﹤0.01% 732
2019
Q3 		$11K Hold
213
– – ﹤0.01% 546
2019
Q2 		$10K Buy
+213
New +$10.2K ﹤0.01% 547

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Citizens Financial Group's EBS Position: Q3 2020 in Review

Citizens Financial Group sold out of Emergent Biosolutions (EBS) in Q3 2020, closing a stake of 213 shares — an estimated $17K sold.

Citizens Financial Group first reported a position in EBS in Q2 2019 and held it in 5 quarters. The position peaked at $17K in Q2 2020. 358 funds tracked by Wall St. Rank hold EBS as of Q3 2020.

  • Citizens Financial Group reported no remaining Emergent Biosolutions position as of Q3 2020 after selling out during the quarter.
  • Citizens Financial Group sold 213 Emergent Biosolutions shares in Q3 2020, an estimated $17K.
  • Citizens Financial Group first reported a position in Emergent Biosolutions in Q2 2019 and held it in 5 quarters.
  • Citizens Financial Group's Emergent Biosolutions position peaked at $17K in Q2 2020.
  • 358 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.